BRI – CVDM Frontiers in Biomedical Science Seminar Series

Joseph Loscalzo, MD, PhD
“The Genomic Basis of the Placebo Effect”

Jane Leopold, MD
“Proteomic Profiling Identifies an Exercise Signature in
Patients with Pulmonary Arterial Hypertension”

This academic year the Brigham Research Institute (BRI) Cardiovascular, Diabetes, and Metabolic Diseases (CVDM) Research Center will be continuing the “CVDM- Frontiers in Biomedical Science Seminar Series” which will include a mix of presentations including Principal Investigator/Fellow collaborative sessions, specialty thematic sessions, work in progress lab presentations, and an external speaker series featuring scientists in the area of CVDM.
The goals of the series are to enrich our academic environment by bringing together the research community to foster networking and collaboration, highlight discoveries, and stimulate new ideas.